Hematopoietic Cell Therapy Products: Determining Potency and Stability
In this webinar, Dr. Jackie Damen of STEMCELL Technologies describes the effects of cryopreservation protocols on the engraftment potential of hematopoietic cell therapy products and the need for standardized potency assays, including the Colony-Forming Unit (CFU) assay, for hematopoietic cell products.
Find answers to more of your questions, answered by Dr. Damen and colleagues following the webinar in this article. Read more >
Find answers to more of your questions, answered by Dr. Damen and colleagues following the webinar in this article. Read more >
Publish Date: April 29, 2020
Views: 0
Related Multimedia
-
7:30How to Standardize Hematopoietic Colony Counting with STEMvision™
Publish Date: January 02, 2019 -
50:59Gene Targeting in Hematopoietic Stem Cells for Basic and Translational Research
Publish Date: November 28, 2018 -
36:48Applications of the Hematopoietic CFU Assay in Toxicity Testing
Publish Date: January 17, 2020